Your Pancreas Controls Insulin, Digestion, and Your Diabetes Risk. Here Is How.

The pancreas sits behind your stomach, about 15 centimetres long, and most people could not point to it on their own body. It runs two entirely separate systems simultaneously. The first is exocrine: it produces digestive enzymes, lipase, amylase, protease, that travel through a duct into the small intestine and break down fat, carbohydrates, and protein from every meal. The second is endocrine: clusters of cells called the islets of Langerhans release hormones directly into the bloodstream. Insulin and glucagon are the two that matter most for diabetes risk.
These two systems share one organ but almost never interfere with each other under normal conditions. When chronic inflammation, excess fat accumulation, or alcohol damage hits the pancreas, both systems can degrade together, which is why people with chronic pancreatitis face a significantly elevated diabetes risk on top of their digestive problems.Insulin is the hormone that allows glucose to enter your cells. After a meal, blood glucose rises. The beta cells in the islets of Langerhans detect that rise and release insulin in response. Insulin binds to receptors on muscle, fat, and liver cells, signalling them to absorb glucose from the blood. Without enough insulin, or when cells stop responding to it properly, glucose stays in the bloodstream. That accumulation is diabetes.
Glucagon does the opposite. When blood glucose drops too low, alpha cells in the same islets release glucagon, which tells the liver to convert stored glycogen back into glucose and release it. The pancreas is therefore running a continuous feedback loop, adjusting output based on what the blood is doing minute to minute.
Type 1 diabetes occurs when the immune system destroys the beta cells entirely. Type 2, which accounts for over 90 percent of diabetes cases in India, occurs when beta cells are still present but either cannot produce enough insulin to meet demand, or when the body's cells have become resistant to its signal. Both outcomes trace directly back to pancreatic function.The Indian Council of Medical Research's ICMR-INDIAB study, one of the largest national diabetes surveys conducted, found that India has over 100 million people living with diabetes, with a further 136 million in the pre-diabetic range. Indian populations develop Type 2 diabetes at lower body weights and younger ages than European populations, a pattern researchers attribute partly to a genetic tendency toward lower beta cell mass and higher insulin resistance relative to body fat percentage.

This matters because the standard BMI thresholds used globally underestimate risk for Indian bodies. A person with a BMI of 23 who would be considered healthy by Western benchmarks may already be carrying enough visceral fat around the pancreas to impair insulin secretion. The fat does not have to be visible. Intra-abdominal fat, particularly fat deposited around and within the pancreas itself, sometimes called fatty pancreas, directly reduces the organ's ability to regulate glucose.Chronic high-calorie intake is the most common driver of fatty pancreas in India's urban population, but it is not the only one. Alcohol is a direct pancreatic toxin; even moderate chronic consumption inflames the organ's ducts and degrades enzyme output. Repeated episodes of acute pancreatitis, whether from gallstones or alcohol, scar tissue that never fully recovers. Each episode reduces functional beta cell capacity.
Certain medications, long-term corticosteroid use, some antipsychotics, impair insulin sensitivity or directly suppress beta cell function. Smoking doubles the risk of pancreatic disease independent of diet. And genetic factors, including mutations in the CFTR gene associated with cystic fibrosis, can compromise exocrine function early and eventually impair the endocrine system alongside it.

The organ has no nerve endings that signal pain until damage is advanced. By the time most people experience symptoms, unexplained weight loss, persistent upper abdominal discomfort, elevated fasting glucose on a routine blood test, the pancreas has already lost a substantial fraction of its working capacity.The most direct protective measure is reducing visceral fat, because fat around the pancreas is the most modifiable risk factor for the majority of people with early-stage insulin resistance. A 2019 study published in Cell Metabolism by Roy Taylor and colleagues at Newcastle University demonstrated that significant caloric restriction in people with Type 2 diabetes of up to six years' duration produced measurable recovery of beta cell function, not just improved glucose control, but actual restoration of insulin secretion capacity. The pancreas, under the right conditions, can partially recover.
Fibre intake slows glucose absorption from the gut, reducing the spike that beta cells must respond to after meals. Millets, ragi, jowar, bajra, have lower glycaemic indices than refined wheat or white rice and are already part of traditional diets across South India, Maharashtra, and Rajasthan. Returning to them from refined grains is not a dietary trend; it is a return to foods the body handles with less pancreatic strain.

Regular physical activity increases insulin sensitivity in muscle cells, which means beta cells do not have to produce as much insulin to achieve the same glucose clearance. Even 30 minutes of brisk walking five days a week produces measurable improvements in insulin sensitivity within weeks.
The pancreas does not announce its decline. Fasting glucose, HbA1c, and lipase levels on routine blood work are the only early signals available, and most people skip them until a symptom forces the issue.
The organ's two jobs, digestion and glucose regulation, look unrelated until one of them starts failing. When beta cells lose capacity, the body compensates with higher insulin output from the remaining cells, masking the problem for years. By the time fasting glucose crosses the diabetic threshold, the pancreas has typically lost 50 percent of its beta cell mass. The glucose number is not the beginning of the problem. It is the point at which the compensation ran out.